awmsg logo

Position statement for cell and gene therapies

It is anticipated that the majority of cell and gene therapies will be considered by the National Institute for Health and Care Excellence (NICE). With the exception of those cell and gene therapies submitted for appraisal by NICE, the All Wales Medicines Strategy Group (AWMSG) will be the body responsible for the appraisal of cell and gene therapies for patients living in Wales if the therapy has been classified as a medicinal product.